Manipulating T Cells to Treat Patients With Cancer
Bruce Feinberg, DO, explains how chimeric antigen receptor T cells were introduced in hematologic malignancies.
Survey Identifies Obstacles to Adoption of CAR T-Cell Therapy for DLBCL
Bruce Feinberg, DO, discusses a survey researching chimeric antigen receptor T-cell therapy’s growing usage by community oncologists for diffuse large B-cell lymphoma.
2 Clarke Drive Cranbury, NJ 08512